MedTrace Logo

Severe Asthma Research Program

NCT01606826 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2025-08-15

No results posted yet for this study

Summary

The mission of the SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Sally Wenzel, MD · University of Pittsburgh

  • Elliot Israel, MD · Brigham & Women's Hospital, Boston

  • Bruce Levy, MD · Brigham & Women's Hospital, Boston

  • John Fahy, MD · University of California, San Francisco

  • Suzy Comhair, MD · The Cleveland Clinic

  • Loren Denlinger, MD · University of Wisconsin, Madison

  • Wendy Moore, MD · Wake Forest University Health Sciences

  • Mario Castro, MD · University of Kansas

  • David Mauger, PhD · Penn State College of Medicine

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01606826 on ClinicalTrials.gov